SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that President and Chief Executive Officer, Sabrina Martucci Johnson, will participate in multiple speaking engagements and deliver a Company corporate presentation during the
BIO International Convention 2026
, taking place June 22-25 in San Diego, California.
As one of the biotechnology industry's premier global gatherings, BIO International Convention brings together thousands of executives, investors, innovators, policymakers and strategic partners to shape the future of healthcare. Daré's participation underscores the Company's growing leadership role in advancing innovation for women and accelerating the development of solutions that have historically been underrepresented in healthcare.
"Women's health represents one of the largest and most underserved opportunities in healthcare today," said Ms. Johnson. "BIO International Convention provides an exceptional platform to engage with global industry leaders, investors and potential collaborators who share a commitment to advancing innovation and improving health outcomes. We are excited to highlight Daré's progress and discuss how our differentiated portfolio is positioned to address significant unmet needs while creating meaningful value for patients, partners and shareholders."
Details of the Company’s participation at BIO International Convention 2026 are as follows:
Invest in San Diego Breakfast
Date:
Monday, June 22, 2026
Time:
7:30 – 9:30 a.m. PT
Location:
IQHQ, 975 Waterfront Place, San Diego, California
Ms. Johnson will participate as a featured speaker during the breakfast program, which highlights the San Diego region's life sciences ecosystem and brings together biotechnology executives, investors and industry stakeholders.
WIB@BIO 2026 Executive Breakfast: Sparking Greatness — Leading Through Inspiration
Date:
Monday, June 22, 2026
Time:
9:00 – 11:00 a.m. PT
Location:
RaDD (IQHQ), 6th Floor, 925 Waterfront Place, San Diego, California
Ms. Johnson will join fellow biotechnology leaders for a discussion focused on leadership, mentorship and fostering innovation across the industry.
BIO International Convention Corporate Presentation
Date:
Tuesday, June 23, 2026
Time:
3:30 p.m. PT
Location:
Theater 4
Ms. Johnson will discuss Daré Bioscience's corporate strategy, commercial and development portfolio and upcoming milestones, highlighting the Company's commitment to delivering impactful solutions that seek to address critical gaps in women's healthcare.
Are We There Yet: The Road to Clinical Development in Women's Health
Date:
Wednesday, June 24, 2026
Time:
4:15 – 5:15 p.m. PT
Location:
Room 26AB
Ms. Johnson will join industry leaders and women's health advocates for a discussion examining the challenges and opportunities in advancing clinical development for women's health products. The session will explore pathways to accelerate innovation, improve patient access and address longstanding gaps in women's healthcare research and development.
Investors and conference attendees interested in meeting with Daré management during the BIO International Convention are encouraged to contact the Company to arrange a meeting. For more information, please visit the
convention website
.
ABOUT DARÉ BIOSCIENCE, INC.
Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions. Every innovation Daré advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré is working to close critical gaps in care using science that serves her needs. For decades, women have been told to "wait it out" or "live with it," while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré is working to change that. Learn more at
darebioscience.com
.
CONTACT:
Daré Bioscience Investor Relations
innovations@darebioscience.com
View the Zacks #1 Rank List
Daré Bioscience to Present Corporate Strategy and Participate in Multiple Speaking Engagements at BIO International Convention 2026
Daré Bioscience CEO Sabrina Johnson will speak at BIO International Convention 2026, highlighting women's health initiatives and innovation.
Quiver AI Summary
Daré Bioscience, Inc. announced that its President and CEO, Sabrina Martucci Johnson, will participate in multiple speaking engagements at the BIO International Convention 2026 in San Diego from June 22-25. This prominent event gathers leaders from the biotechnology industry to discuss healthcare innovations. Johnson’s participation highlights Daré's commitment to advancing women's health solutions that are often overlooked. She will address topics on leadership, clinical development challenges in women's health, and the company's strategies for addressing critical healthcare gaps. Daré aims to foster innovation and improve health outcomes for women, focusing on areas such as contraception, menopause, and sexual health. Attendees are encouraged to meet with Daré's management during the convention for further discussions.
Potential Positives
Potential Negatives
FAQ
What is Daré Bioscience's role at BIO International Convention 2026?
Daré Bioscience's CEO will participate in multiple speaking engagements and a corporate presentation highlighting women's health innovations.
When will the BIO International Convention 2026 be held?
The convention will take place from June 22-25, 2026, in San Diego, California.
What topics will be discussed by Daré's CEO at the convention?
Ms. Johnson will discuss leadership in biotechnology, women’s health clinical development, and Daré's corporate strategy.
How does Daré Bioscience address women's healthcare gaps?
Daré focuses on developing innovative solutions for women's health issues that have been historically underserved and overlooked.
Who should contact Daré for meetings during the convention?
Investors and attendees interested in meeting with Daré management are encouraged to reach out to arrange a meeting.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$DARE Hedge Fund Activity
We have seen 13 institutional investors add shares of $DARE stock to their portfolio, and 12 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Full Release
SAN DIEGO, June 18, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that President and Chief Executive Officer, Sabrina Martucci Johnson, will participate in multiple speaking engagements and deliver a Company corporate presentation during the BIO International Convention 2026 , taking place June 22-25 in San Diego, California.
As one of the biotechnology industry's premier global gatherings, BIO International Convention brings together thousands of executives, investors, innovators, policymakers and strategic partners to shape the future of healthcare. Daré's participation underscores the Company's growing leadership role in advancing innovation for women and accelerating the development of solutions that have historically been underrepresented in healthcare.
"Women's health represents one of the largest and most underserved opportunities in healthcare today," said Ms. Johnson. "BIO International Convention provides an exceptional platform to engage with global industry leaders, investors and potential collaborators who share a commitment to advancing innovation and improving health outcomes. We are excited to highlight Daré's progress and discuss how our differentiated portfolio is positioned to address significant unmet needs while creating meaningful value for patients, partners and shareholders."
Details of the Company’s participation at BIO International Convention 2026 are as follows:
Invest in San Diego Breakfast
Date: Monday, June 22, 2026
Time: 7:30 – 9:30 a.m. PT
Location: IQHQ, 975 Waterfront Place, San Diego, California
Ms. Johnson will participate as a featured speaker during the breakfast program, which highlights the San Diego region's life sciences ecosystem and brings together biotechnology executives, investors and industry stakeholders.
WIB@BIO 2026 Executive Breakfast: Sparking Greatness — Leading Through Inspiration
Date: Monday, June 22, 2026
Time: 9:00 – 11:00 a.m. PT
Location: RaDD (IQHQ), 6th Floor, 925 Waterfront Place, San Diego, California
Ms. Johnson will join fellow biotechnology leaders for a discussion focused on leadership, mentorship and fostering innovation across the industry.
BIO International Convention Corporate Presentation
Date: Tuesday, June 23, 2026
Time: 3:30 p.m. PT
Location: Theater 4
Ms. Johnson will discuss Daré Bioscience's corporate strategy, commercial and development portfolio and upcoming milestones, highlighting the Company's commitment to delivering impactful solutions that seek to address critical gaps in women's healthcare.
Are We There Yet: The Road to Clinical Development in Women's Health
Date: Wednesday, June 24, 2026
Time: 4:15 – 5:15 p.m. PT
Location: Room 26AB
Ms. Johnson will join industry leaders and women's health advocates for a discussion examining the challenges and opportunities in advancing clinical development for women's health products. The session will explore pathways to accelerate innovation, improve patient access and address longstanding gaps in women's healthcare research and development.
Investors and conference attendees interested in meeting with Daré management during the BIO International Convention are encouraged to contact the Company to arrange a meeting. For more information, please visit the convention website .
ABOUT DARÉ BIOSCIENCE, INC.
Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions. Every innovation Daré advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré is working to close critical gaps in care using science that serves her needs. For decades, women have been told to "wait it out" or "live with it," while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré is working to change that. Learn more at darebioscience.com .
CONTACT:
Daré Bioscience Investor Relations
innovations@darebioscience.com
Read full article here »